Patents by Inventor Javier Cote-Sierra

Javier Cote-Sierra has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of use
    Patent number: 10376475
    Abstract: The present invention relates to a novel method of treatment of acne in a human patient in need thereof, comprising administering topically to said patient an effective amount of the compound 3,5-Dihydroxy-4-isopropyl-trans-stilbene (Compound 1) or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: December 9, 2015
    Date of Patent: August 13, 2019
    Assignee: DERMAVANT SCIENCES GMBH
    Inventors: Javier Cote-Sierra, Susan H. Smith, Steven M. Frey
  • NOVEL METHOD OF USE
    Publication number: 20170360719
    Abstract: The present invention relates to a novel method of treatment of acne in a human patient in need thereof, comprising administering topically to said patient an effective amount of the compound 3,5-Dihydroxy-4-isopropyl-trans-stilbene (Compound 1) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: December 9, 2015
    Publication date: December 21, 2017
    Inventors: Javier COTE-SIERRA, Susan H. SMITH, Steven M. FREY
  • Inflammation in vivo model
    Patent number: 9271479
    Abstract: The present invention relates to a non-human animal deficient in the N-terminal domain of the IL-33 gene. Also provided herein is the use of said non-human animal as an in vivo model of inflammatory diseases, especially with regard to screening methods for anti-inflammatory compounds, and methods for evaluating and optimizing the pharmacological properties of a given anti-inflammatory compound.
    Type: Grant
    Filed: September 3, 2014
    Date of Patent: March 1, 2016
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Javier Cote-Sierra, Antonio Iglesias, Claas Aiko Meyer
  • Novel Inflammation in Vivo Model
    Publication number: 20150026832
    Abstract: The present invention relates to a non-human animal deficient in the N-terminal domain of the IL-33 gene. Also provided herein is the use of said non-human animal as an in vivo model of inflammatory diseases, especially with regard to screening methods for anti-inflammatory compounds, and methods for evaluating and optimising the pharmacological properties of a given anti-inflammatory compound.
    Type: Application
    Filed: September 3, 2014
    Publication date: January 22, 2015
    Inventors: Javier Cote-Sierra, Antonio Iglesias, Claas Aiko Meyer
  • Novel Inflammation to vivo model
    Publication number: 20130318641
    Abstract: The present invention relates to a non-human animal deficient in the N-terminal domain of the IL-33 gene. Also provided herein is the use of said non-human animal as an in vivo model of inflammatory diseases, especially with regard to screening methods for anti-inflammatory compounds, and methods for evaluating and optimising the pharmacological properties of a given anti-inflammatory compound.
    Type: Application
    Filed: April 22, 2013
    Publication date: November 28, 2013
    Inventors: Javier Cote-Sierra, Antonio Iglesias, Claas Aiko Meyer